Budesonide/formoterol treatment decreased COPD exacerbations Budesonide/formoterol treatment decreased exacerbations in COPD after 3 months. Patients with moderate-to-very-severe chronic obstructive ...
The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
Chronic obstructive pulmonary disease (COPD) management should take into account patients’ comorbidities, according to a poster presented at the Academy of Managed Care Pharmacy Nexus 2021 meeting.
Background In real-world chronic obstructive pulmonary disease (COPD) care, poor adherence often leads to treatment ...
Please provide your email address to receive an email when new articles are posted on . Common genetic variants do not appear to play an important role in predicting acute exacerbations of COPD or ...
telemedicine Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD. The risk for symptom exacerbation reduced after PPI treatment for patients with GERD ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Inhaled triple ...
In a retrospective analysis of patients with chronic obstructive pulmonary disease (COPD), those whose exacerbations were treated with systemic corticosteroids alone, or together with antibiotics, did ...
—The use of antibiotics in combination with oral corticosteroids to treat patients with mild-to-moderate exacerbations of COPD is the subject of much clinical debate. Reviewed by Ware Kuschner, MD, ...
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease affecting at least 15 million American adults. It’s also the fourth leading cause of disease-attributed death. This makes ...
A digital health application for reporting symptoms of chronic obstructive pulmonary disease (COPD) facilitated early detection and treatment of COPD exacerbation symptoms, according to an analysis. A ...
Higher serum levels of C-reactive protein at admission, as well as use of penicillin or cephalosporin, predicted in-hospital treatment failure for patients hospitalized for COPD exacerbation, ...